Giving HPV jab to women with pre-cancerous cells on their cervix may ward off cancer, study suggests - Daily Mail

Giving women with pre-cancerous cells on their cervix the HPV vaccine could cut their risk of developing cervical cancer, scientists say.

Imperial College London experts reviewed studies involving thousands of women vaccinated against HPV who had to have pre-cancerous cells removed.

Imperial College London researchers reviewed studies involving thousands of women vaccinated against HPV who had to have pre-cancerous cells removed.

It can lead to genital warts, and is also known to cause cervical cancer by creating an abnormal tissue growth.

But the latest study suggests that women with pre-cancerous cells on their cervix — scientifically known as cervical intra-epithelial neoplasia (CIN) — might benefit from receiving it.

Once a woman is identified as having high-grade pre-cancerous cells on her cervix she has a life-long risk of developing cervical cancer. .

Earlier research suggests that giving a preventative HPV vaccine alongside surgery to remove abnormal CIN cells can help reduce the risk to women

To further explore this, experts analysed results from 18 studies to assess whether HPV jabs reduced the risk of abnormal cells recurring after surgery

The findings were even stronger among women who were found to carry the strains of the virus most linked to cervical cancer